Novel EGFR inhibitors attenuate Ang II-induced cardiac hypertrophy

被引：0
|
作者：
Peng, Kesong [1 ]
Pan, Yong [1 ]
Liang, Guang [1 ]
机构：
[1] Wenzhou Med Univ, Sch Pharm, Chem Biol Res Ctr, Wenzhou, Peoples R China
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
794.3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
    Peng, Kesong
    Tian, Xinqiao
    Qian, Yuanyuan
    Skibba, Melissa
    Zou, Chunpeng
    Liu, Zhiguo
    Wang, Jingying
    Xu, Zheng
    Li, Xiaokun
    Liang, Guang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (03) : 482 - 494
  • [2] Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats
    Wu, R
    Laplante, MA
    de Champlain, J
    HYPERTENSION, 2005, 45 (06) : 1139 - 1144
  • [3] Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
    Lee, Chang Youn
    Park, Han Ki
    Lee, Bok-Sim
    Jeong, Seongtae
    Hyun, Sung-Ae
    Choi, Jung-Won
    Kim, Sang Woo
    Lee, Seahyoung
    Lim, Soyeon
    Hwang, Ki-Chul
    MOLECULES, 2020, 25 (22):
  • [4] Impact of NO-GC1 on the Ang II-induced cardiac hypertrophy and vascular remodelling
    Broekmans, K.
    Russwurm, M.
    Koesling, D.
    Mergia, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 14 - 14
  • [5] Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-KB signaling
    Ma, En
    Wu, Celiang
    Chen, Jinxiao
    Wo, Da
    Ren, Dan-ni
    Yan, Hongwei
    Peng, Luying
    Zhu, Weidong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [6] Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation
    Ge, Weipeng
    Hou, Cuiliu
    Zhang, Wei
    Guo, Xiaoxiao
    Gao, Pan
    Song, Xiaomin
    Gao, Ran
    Liu, Ying
    Guo, Wenjun
    Li, Bolun
    Zhao, Hongmei
    Wang, Jing
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 152 : 52 - 68
  • [7] Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy
    Baker, KM
    Chernin, MI
    Schreiber, T
    Sanghi, S
    Haiderzaidi, S
    Booz, GW
    Dostal, DE
    Kumar, R
    REGULATORY PEPTIDES, 2004, 120 (1-3) : 5 - 13
  • [8] Metabolomics in Angiotensin II-Induced Cardiac Hypertrophy
    Mervaala, Eero
    Biala, Agnieszka
    Merasto, Saara
    Lempiainen, Juha
    Mattila, Ismo
    Martonen, Essi
    Eriksson, Ove
    Louhelainen, Marjut
    Finckenberg, Piet
    Kaheinen, Petri
    Muller, Dominik N.
    Luft, Friedrich C.
    Lapatto, Risto
    Oresic, Matej
    HYPERTENSION, 2010, 55 (02) : 508 - 515
  • [9] Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative Stress
    Du, Yao
    Han, Jibo
    Zhang, Haixia
    Xu, Jianjiang
    Jiang, Liqin
    Ge, Weihong
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (04) : 326 - 335
  • [10] Sirt4 Accelerates Ang II-induced Pathological Cardiac Hypertrophy by Inhibiting Mnsod Activity
    Liu, Depei
    Luo, Yu-Xuan
    Tang, Xiaoqiang
    An, Xi-Zhou
    Xie, Xue-Min
    Chen, Xiao-Feng
    Zhao, Xiang
    Hao, De-Long
    Chen, Hou-Zao
    CIRCULATION RESEARCH, 2016, 119
12345